Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,599 | 3,433 | 6,565 | 4,450 | 1,657 |
| Marketable Securities | 83 | 759 | 108 | 751 | N/A |
| Receivables | 432 | 427 | 426 | 473 | 443 |
| Inventories | 22 | 23 | 26 | 60 | N/A |
| Other current assets | 3,713 | 2,715 | 0 | 561 | 710 |
| TOTAL | $9,789 | $7,988 | $7,654 | $7,111 | $3,628 |
| Non-Current Assets | |||||
| PPE Net | 597 | 599 | 526 | 528 | 512 |
| Investments And Advances | 871 | 904 | 2,086 | 1,007 | 1,096 |
| Other Non-Current Assets | 2,525 | 2,576 | 3,433 | 3,710 | 3,710 |
| TOTAL | $3,993 | $4,079 | $6,044 | $5,244 | $5,317 |
| Total Assets | $13,783 | $12,067 | $13,698 | $12,355 | $8,945 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 464 | 446 | 393 | 315 | 321 |
| Accrued Expenses | 1,247 | 1,248 | 1,301 | 1,134 | 1,865 |
| Other current liabilities | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $3,646 | $3,664 | $3,692 | $3,439 | $4,376 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 8 | N/A | 104 | 237 |
| Other Non-Current Liabilities | 1,045 | 1,126 | 105 | 1,302 | 3,898 |
| TOTAL | $956 | $1,042 | $1,135 | $1,326 | $4,053 |
| Total Liabilities | $4,602 | $4,705 | $4,828 | $4,765 | $8,429 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,263 | 3,231 | 3,031 | 2,861 | 2,447 |
| Common Shares | 32 | 30 | 29 | 28 | 25 |
| Retained earnings | -46,336 | -44,477 | -37,942 | -30,549 | -28,743 |
| Other shareholders' equity | -1,757 | -1,771 | -2,331 | -2,606 | -2,768 |
| TOTAL | $9,181 | $7,361 | $8,870 | $7,590 | $516 |
| Total Liabilities And Equity | $13,783 | $12,067 | $13,698 | $12,355 | $8,945 |